Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General Hospital

 Objective: To evaluate the efficacy of Zolpidem and Nigella sativa compared to placebo in treatment of sleep disturbance in healthy postmenopausal women. Menopause is a period that diagnosed after 12 months of amenorrhea and is characterized by a group of symptoms that include irregular menses; va...

Full description

Bibliographic Details
Main Authors: Mojgan Asadi, Fatemeh Molavi, Mostafa Qorbani, Fatemeh Davari Tanha
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-11-01
Series:Journal of Family and Reproductive Health
Subjects:
Online Access:https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1524
id doaj-a96ef4e580c94b5a80bec8fb1d9b5d18
record_format Article
spelling doaj-a96ef4e580c94b5a80bec8fb1d9b5d182021-04-02T18:22:35ZengTehran University of Medical SciencesJournal of Family and Reproductive Health1735-89491735-93922020-11-0114310.18502/jfrh.v14i3.4672Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General HospitalMojgan Asadi0Fatemeh Molavi1Mostafa Qorbani2Fatemeh Davari Tanha3Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranDepartment of Internal Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranNon-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran AND Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, IranDepartment of Reproductive Endocrinology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran  Objective: To evaluate the efficacy of Zolpidem and Nigella sativa compared to placebo in treatment of sleep disturbance in healthy postmenopausal women. Menopause is a period that diagnosed after 12 months of amenorrhea and is characterized by a group of symptoms that include irregular menses; vasomotor and urogenital symptoms. The effects of non-hormonal therapies are being widely researched on menopause symptoms. There has been no study to compare Zolpidem and Nigella sativa versus placebo. Materials and methods: In this double-blind, placebo controlled trial, we compared the effect of Zolpidem with Nigella sativa and placebo in reducing sleep quality in 60 menopausal women. The prior and the later results were compared. We divided the patients into three groups after history taking and physical examination and filling the Pittsburgh questionnaire. Each group received their medication as the following order: Group A: Zolpidem, Group B: Nigella sativa, Group C: placebo. The first group received Zolpidem with the dose of 5 mg for 8 weeks. The second group received Nigella sativa with the dose of 600 mg for 8 weeks. The third group received placebo for 8 weeks. After two months, the Pittsburg questionnaire was filled again. Results: In the nigella sativa group, we had not significant improvement in sleep quality (p =0.07), hot flashes (p =0.15), palpitation (p =0.56) and night sweets (p =0.08).  In zolpidem group, we have seen lack of improvement of hot flashes (p =0.73), and palpitation (p =0.36), which are nonsignificant statistically according to p values, but in zolpidem group, we had significant improvement in sleep quality (p =0.01), and night sweats (p =0.049). Conclusion: It seems that zolpidem has some effect on improving the quality of sleep in postmenopausal women. zolpidem also is good for night sweats. Nigella sativa was not effective in vasomotor symptoms and sleep quality.      https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1524ZolpidemNigella SativaSleep DisorderMenopause
collection DOAJ
language English
format Article
sources DOAJ
author Mojgan Asadi
Fatemeh Molavi
Mostafa Qorbani
Fatemeh Davari Tanha
spellingShingle Mojgan Asadi
Fatemeh Molavi
Mostafa Qorbani
Fatemeh Davari Tanha
Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General Hospital
Journal of Family and Reproductive Health
Zolpidem
Nigella Sativa
Sleep Disorder
Menopause
author_facet Mojgan Asadi
Fatemeh Molavi
Mostafa Qorbani
Fatemeh Davari Tanha
author_sort Mojgan Asadi
title Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General Hospital
title_short Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General Hospital
title_full Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General Hospital
title_fullStr Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General Hospital
title_full_unstemmed Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General Hospital
title_sort comparative efficacy of zolpidem and nigella sativa in treatment of sleep disorder and vasomotor symptoms in menopausal women of women’s general hospital
publisher Tehran University of Medical Sciences
series Journal of Family and Reproductive Health
issn 1735-8949
1735-9392
publishDate 2020-11-01
description  Objective: To evaluate the efficacy of Zolpidem and Nigella sativa compared to placebo in treatment of sleep disturbance in healthy postmenopausal women. Menopause is a period that diagnosed after 12 months of amenorrhea and is characterized by a group of symptoms that include irregular menses; vasomotor and urogenital symptoms. The effects of non-hormonal therapies are being widely researched on menopause symptoms. There has been no study to compare Zolpidem and Nigella sativa versus placebo. Materials and methods: In this double-blind, placebo controlled trial, we compared the effect of Zolpidem with Nigella sativa and placebo in reducing sleep quality in 60 menopausal women. The prior and the later results were compared. We divided the patients into three groups after history taking and physical examination and filling the Pittsburgh questionnaire. Each group received their medication as the following order: Group A: Zolpidem, Group B: Nigella sativa, Group C: placebo. The first group received Zolpidem with the dose of 5 mg for 8 weeks. The second group received Nigella sativa with the dose of 600 mg for 8 weeks. The third group received placebo for 8 weeks. After two months, the Pittsburg questionnaire was filled again. Results: In the nigella sativa group, we had not significant improvement in sleep quality (p =0.07), hot flashes (p =0.15), palpitation (p =0.56) and night sweets (p =0.08).  In zolpidem group, we have seen lack of improvement of hot flashes (p =0.73), and palpitation (p =0.36), which are nonsignificant statistically according to p values, but in zolpidem group, we had significant improvement in sleep quality (p =0.01), and night sweats (p =0.049). Conclusion: It seems that zolpidem has some effect on improving the quality of sleep in postmenopausal women. zolpidem also is good for night sweats. Nigella sativa was not effective in vasomotor symptoms and sleep quality.     
topic Zolpidem
Nigella Sativa
Sleep Disorder
Menopause
url https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1524
work_keys_str_mv AT mojganasadi comparativeefficacyofzolpidemandnigellasativaintreatmentofsleepdisorderandvasomotorsymptomsinmenopausalwomenofwomensgeneralhospital
AT fatemehmolavi comparativeefficacyofzolpidemandnigellasativaintreatmentofsleepdisorderandvasomotorsymptomsinmenopausalwomenofwomensgeneralhospital
AT mostafaqorbani comparativeefficacyofzolpidemandnigellasativaintreatmentofsleepdisorderandvasomotorsymptomsinmenopausalwomenofwomensgeneralhospital
AT fatemehdavaritanha comparativeefficacyofzolpidemandnigellasativaintreatmentofsleepdisorderandvasomotorsymptomsinmenopausalwomenofwomensgeneralhospital
_version_ 1721551933802545152